Abstract：Alopecia is a common disease in clinics, which can be treated with syndrome differentiation in traditional Chinese medicine and achieve better results. Professor Li Hao considers that the main pathogenesis of alopecia in traditional Chinese medicine is “deficiency of blood and excess of retained fluid”. When yin blood is insufficient, hair is lost nourishment, because hair roots are empty and withered. In addition, water and dampness erode hair roots, accelerating their decay and shedding. The liver stores blood and regulates the operation of blood, and the spleen is the source of qi and blood. The stagnation of wood is stronger than earth, which causes dysfunction of spleen in transportation, so water and dampness invade the top of the head. Blood deficiency will also cause blood flow poorly. Unsmooth blood circulation results in water retention. The pathogenesis is a combination of liver and spleen dysfunction with abnormalities in blood and water. Danggui Shaoyao Powder is composed of three “blood medicines” Angelicae Sinensis Radix, Paeonia lactiflora Pall., and Chuanxiong Rhizoma, and three “water medicines” Poria, Alismatis Rhizoma, and Atractylodis Macrocephalae Rhizoma. It has the effect of invigorating the spleen and dispersing the stagnated liver-energy, nourishing blood and invigorating blood circulation, eliminating dampness and diuresis. It harmonizes the liver and spleen and treats blood and water simultaneously. When using Danggui Shaoyao Powder to treat alopecia, Professor Li Hao usually reduces the amount of Paeonia lactiflora Pall. increases the amount of Angelicae Sinensis Radix and Poria, and takes into account invigorating the liver and kidney as appropriate, or accompanied by eliminating heat and removing stasis.
李泽惠 杨洋 刘南阳 张震 裴卉 李浩. 李浩教授运用当归芍药散从“血虚水盛”论治脱发的经验[J]. 中国医药导报, 2023, 20(26): 148-151.
LI Zehui YANG Yang LIU Nanyang ZHANG Zhen PEI Hui LI Hao. Professor Li Hao’s experience in treating alopecia from “deficiency of blood and excess of retained fluid” with Danggui Shaoyao Powder. 中国医药导报, 2023, 20(26): 148-151.
京公网安备 11010502046598号